SCHEMBL4578709

SCHEMBL4578709

O=C(O)CC1(O)CN(C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.49
OPRM1 P35372 6/20 0.49
OPRD1 P41143 6/20 0.49
OPRK1 P41145 6/20 0.49
OPRL1 P41146 6/20 0.49
CYP2D6 P10635 5/20 0.46
HIF1A Q16665 2/20 0.46
CYP2C9 P11712 4/20 0.46
CYP2C19 P33261 2/20 0.46
CACNA1H O95180 1/20 0.45
CACNA2D1 P54289 1/20 0.45
CACNA1B Q00975 1/20 0.45
CACNB1 Q02641 1/20 0.45
CACNA1C Q13936 1/20 0.45
USP2 O75604 3/20 0.45
CYP1A2 P05177 2/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3834657 0.80 OPRM1 (0.45) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL13317173 0.79 OPRM1 (0.51) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL2142315 0.79 OPRM1 (0.51) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL69083 0.79 OPRM1 (0.56) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL1742229 0.78 OPRM1 (0.71) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL1489316 0.78 OPRM1 (0.50) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL1488335 0.77 CYP3A4 (0.53) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL7691375 0.77 OPRL1 (0.60) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL3224569 0.75 OPRM1 (0.48) CYP3A4OPRM1OPRD1OPRK1OPRL1
SCHEMBL10569014 0.75 CYP3A4 (0.54) CYP3A4OPRM1OPRD1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111643496-A Methods of using MEK inhibitors 埃克塞利希斯股份有限公司 2020-09-11 CN disclosed
CN-105106199-A Methods of using MEK inhibitors EXELIXIS INC 2015-12-02 CN disclosed
EP-1934174-A1 AZETIDINES AS MEK INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2008-06-25 EP disclosed
WO-2007044515-A1 AZETIDINES AS MEK INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2007-04-19 WO disclosed